𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma

✍ Scribed by Revathi Suppiah; Philip E. Shaheen; Paul Elson; Seema A. Misbah; Laura Wood; Robert J. Motzer; Slyvie Negrier; Steven W. Andresen; Ronald M. Bukowski

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
129 KB
Volume
107
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prognostic factors for survival in patie
Prognostic factors for survival in patients with brain metastases from renal cell carcinoma
✍ StΓ©phane Culine; Mohamed Bekradda; Andrew Kramar; Annie Rey; Bernard Escudier; J πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

The authors thank S. Ne Β΄grier, M.D., A. Ravaud, M.D., and G. Chvetzoff for providing the clinical charts of patients included in the external data set.

Prognostic nomogram for sunitinib in pat
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
✍ Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi